Market Brief: Why Rate Hikes No Longer Work

Seeking Alpha - Mon, 09/14/2026 - 09:14

Ondas acquires GATE Technologies, Bron Technologies for $205M

Seeking Alpha - Mon, 09/14/2026 - 09:11

Regional REIT Limited 2026 Q2 - Results - Earnings Call Presentation

Seeking Alpha - Mon, 09/14/2026 - 09:11

AgEagle Aerial Systems gains army drone exposure as Agilis Air raises $1.4M

Seeking Alpha - Mon, 09/14/2026 - 09:07

Devon Energy: The Coterra Merger Meets A Powerful Oil Price Tailwind

Seeking Alpha - Mon, 09/14/2026 - 09:05

Crypto stocks up as final draft of Republicans' Clarity Act text is said to address ethics restrictions

Seeking Alpha - Mon, 09/14/2026 - 09:05

Situational Awareness, Options Bets, And Pacing AI Frontier

Seeking Alpha - Mon, 09/14/2026 - 09:03

Exelixis: Why The 3-Month Delay Is More Negative Than It May Seem (Downgrade)

Seeking Alpha - Mon, 09/14/2026 - 09:00

Pan American Silver: Softer Output With Rising Costs

Seeking Alpha - Mon, 09/14/2026 - 09:00

Lifecore Biomedical: A Messy Balance Sheet, A Much Better Business

Seeking Alpha - Mon, 09/14/2026 - 08:59

GE Aerospace advances XA102 engine toward assembly under Air Force program

Seeking Alpha - Mon, 09/14/2026 - 08:57

ArcelorMittal says two killed in missile strike on Ukraine plant

Seeking Alpha - Mon, 09/14/2026 - 08:57

Stocks to watch on Monday: GLW, KMB, NVDA & more

Seeking Alpha - Mon, 09/14/2026 - 08:56

Sachem Capital: How The Merger Will Impact The Common Stock, Baby Bonds, And Preferred Stock

Seeking Alpha - Mon, 09/14/2026 - 08:55

Allegiant Travel attracts a bull rating from UBS on merger synergies' potential

Seeking Alpha - Mon, 09/14/2026 - 08:51

WeRide reports 1H results

Seeking Alpha - Mon, 09/14/2026 - 08:51

The Future Growth of Specialized Healthcare Services

TalkMarkets - Mon, 09/14/2026 - 08:51
The Future Growth of Specialized Healthcare Services

AI Doomsday Fears Shouldn't Crash The AI Boom

Seeking Alpha - Mon, 09/14/2026 - 08:50

T1 Energy: G2_Austin Can Change Profits From 2027

Seeking Alpha - Mon, 09/14/2026 - 08:48

Inhibrx: 'Strong Buy' Maintained With Ozekibart Action Date On The Horizon And Study Win With INBRX-106

Seeking Alpha - Mon, 09/14/2026 - 08:46

Pages